Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
Chronic hepatitis C virus (HCV) infection is a major cause of hepatic fibrosis and cirrhosis, with a risk for the development of hepatocellular carcinoma (HCC). Although highly effective direct-acting antivirals (DAAs) are available, the incidence, morbidity, and mortality of HCV-associated HCC are...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
August 2024
|
| In: |
Current opinion in virology
Year: 2024, Volume: 67, Pages: 1-8 |
| ISSN: | 1879-6265 |
| DOI: | 10.1016/j.coviro.2024.101423 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.coviro.2024.101423 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1879625724000373 
|
| Author Notes: | Felix Fiehn, Claudia Beisel and Marco Binder |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1912918196 | ||
| 003 | DE-627 | ||
| 005 | 20250716220312.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241218s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.coviro.2024.101423 |2 doi | |
| 035 | |a (DE-627)1912918196 | ||
| 035 | |a (DE-599)KXP1912918196 | ||
| 035 | |a (OCoLC)1528015587 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fiehn, Felix |d 1997- |e VerfasserIn |0 (DE-588)1317523989 |0 (DE-627)1879418770 |4 aut | |
| 245 | 1 | 0 | |a Hepatitis C virus and hepatocellular carcinoma |b carcinogenesis in the era of direct-acting antivirals |c Felix Fiehn, Claudia Beisel and Marco Binder |
| 264 | 1 | |c August 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar 25 June 2024, Version des Artikels 25 June 2024 | ||
| 500 | |a Gesehen am 16.12.2024 | ||
| 520 | |a Chronic hepatitis C virus (HCV) infection is a major cause of hepatic fibrosis and cirrhosis, with a risk for the development of hepatocellular carcinoma (HCC). Although highly effective direct-acting antivirals (DAAs) are available, the incidence, morbidity, and mortality of HCV-associated HCC are still high. This article reviews the current knowledge of the mechanisms of HCV-induced carcinogenesis with a special focus on those processes that continue after virus clearance and outlines implications for patient surveillance after DAA treatment. | ||
| 700 | 1 | |a Beisel, Claudia |d 1982- |e VerfasserIn |0 (DE-588)1015931286 |0 (DE-627)66990709X |0 (DE-576)351301968 |4 aut | |
| 700 | 1 | |a Binder, Marco |e VerfasserIn |0 (DE-588)13571379X |0 (DE-627)69371171X |0 (DE-576)300603509 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in virology |d Amsterdam [u.a.] : Elsevier, 2011 |g 67(2024) vom: Aug., Artikel-ID 101423, Seite 1-8 |h Online-Ressource |w (DE-627)661267059 |w (DE-600)2611378-8 |w (DE-576)346017076 |x 1879-6265 |7 nnas |a Hepatitis C virus and hepatocellular carcinoma carcinogenesis in the era of direct-acting antivirals |
| 773 | 1 | 8 | |g volume:67 |g year:2024 |g month:08 |g elocationid:101423 |g pages:1-8 |g extent:8 |a Hepatitis C virus and hepatocellular carcinoma carcinogenesis in the era of direct-acting antivirals |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.coviro.2024.101423 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1879625724000373 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241218 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 13571379X |a Binder, Marco |m 13571379X:Binder, Marco |d 140000 |e 140000PB13571379X |k 0/140000/ |p 3 |y j | ||
| 998 | |g 1015931286 |a Beisel, Claudia |m 1015931286:Beisel, Claudia |d 910000 |d 910100 |e 910000PB1015931286 |e 910100PB1015931286 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1317523989 |a Fiehn, Felix |m 1317523989:Fiehn, Felix |d 50000 |e 50000PF1317523989 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1912918196 |e 4638425062 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Online verfügbar 25 June 2024, Version des Artikels 25 June 2024","Gesehen am 16.12.2024"],"recId":"1912918196","person":[{"family":"Fiehn","role":"aut","given":"Felix","display":"Fiehn, Felix"},{"given":"Claudia","display":"Beisel, Claudia","role":"aut","family":"Beisel"},{"family":"Binder","role":"aut","given":"Marco","display":"Binder, Marco"}],"language":["eng"],"name":{"displayForm":["Felix Fiehn, Claudia Beisel and Marco Binder"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"August 2024"}],"relHost":[{"recId":"661267059","title":[{"title":"Current opinion in virology","title_sort":"Current opinion in virology"}],"id":{"zdb":["2611378-8"],"eki":["661267059"],"issn":["1879-6265"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2011-","publisher":"Elsevier","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"2011"}],"language":["eng"],"part":{"text":"67(2024) vom: Aug., Artikel-ID 101423, Seite 1-8","extent":"8","pages":"1-8","volume":"67","year":"2024"},"note":["Gesehen am 14.05.20"],"pubHistory":["2011 -"],"disp":"Hepatitis C virus and hepatocellular carcinoma carcinogenesis in the era of direct-acting antiviralsCurrent opinion in virology","type":{"media":"Online-Ressource","bibl":"periodical"}}],"id":{"eki":["1912918196"],"doi":["10.1016/j.coviro.2024.101423"]},"physDesc":[{"noteIll":"Illustrationen","extent":"8 S."}],"title":[{"title":"Hepatitis C virus and hepatocellular carcinoma","subtitle":"carcinogenesis in the era of direct-acting antivirals","title_sort":"Hepatitis C virus and hepatocellular carcinoma"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a FIEHNFELIXHEPATITISC2024 | ||